To build scope & capacity for clinical research
New evidence based knowledge
Research into effective clinical practice
- About Us
- Contact Us
For free and confidential advice about alcohol and other drugs, call the National Alcohol and Other Drug hotline: 1800 250 015. It will automatically direct you to the Alcohol and Drug Information Service in your state or territory. Click here for more information
An online text-based counselling for people concerned about their own drinking or drug use. The service is equally available to people concerned about a family member, relative or friend. Click here for more information
David Goodman-Meza, MD, MAS, is an Assistant Professor in the Division of Infectious Diseases at the David Geffen School of Medicine at University of California, Los Angeles, USA. Dr. Goodman-Meza is a Mexican-American physician-scientist. He completed his medical degree with honors at Universidad Autonoma de Baja California in Tijuana, Mexico. He received his master’s degree in clinical research at UCSD and participated in a NIDA T32 post-doctoral training program at UCSD’s Division of Global Public Health mentored by Steffanie Strathdee and Thomas Patterson. He moved to New York to complete his internal medicine residency at Albert Einstein College of Medicine/Jacobi Medical Center. He completed his fellowship in Infectious Diseases at UCLA, where he was mentored by Steve Shoptaw.
Dr. Goodman-Meza’s research is focused at the relationship of substance use disorders and infectious diseases, and the impact of substance use disorders treatment on infectious diseases treatment and prevention outcomes. He is currently a recipient of an NIDA K08 Career Development Award where he is training in the use of natural language processing and machine learning to evaluate outcomes of people who inject drugs who are admitted due to Staphylococcus aureus bacteremia. He is also the Los Angeles principal investigator on a NIDA Clinical Trials network study evaluating buprenorphine for treatment of methamphetamine use disorder and a HPTN study evaluation the use of mobile units and navigation for treatment of opioid use disorder.